News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SkyePharma Inc. (SKYE) Trims H1 Loss, Meeting FDA on Flutiform


8/21/2009 6:37:54 AM

Bookmark and Share

Reuters -- British drug delivery specialist SkyePharma trimmed first-half losses on lower revenue and said it remain confident about its key new lung drug Flutiform, despite a delay in the United States.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES